Current:Home > FinanceNew omicron subvariants now dominant in the U.S., raising fears of a winter surge-InfoLens
New omicron subvariants now dominant in the U.S., raising fears of a winter surge
View Date:2024-12-23 11:41:57
Two new omicron subvariants have become dominant in the United States, raising fears they could fuel yet another surge of COVID-19 infections, according to estimates released Friday by the Centers for Disease Control and Prevention.
The subvariants — called BQ.1 and BQ.1.1 -- appear to be among the most adept yet at evading immunity from vaccination and previous infection, and have now overtaken the BA.5 omicron subvariant that has dominated in the U.S. since the summer.
"It's a little bit eerily familiar," says Dr. Jeremy Luban of the University of Massachusetts, who's been tracking variants since the pandemic began.
"This time of year last year we were optimistic. We were coming out of the delta wave, and it was steadily decreasing, and we went into Thanksgiving to wake up to omicron. So there is this sort of déjà vu feeling from last year," Luban says.
BQ.1 and BQ.1.1, had been quickly gaining ground in the U.S. in recent weeks. On Friday, they officially overtook BA.5, accounting for an estimated 44% of all new infections nationwide and nearly 60% in some parts of the country, such as New York and New Jersey, according to the CDC's estimates. BA.5 now accounts for an estimated 30% of all new infections nationwide.
Recent laboratory studies indicate that new mutations in the virus's spike protein appear to make BQ.1 and BQ.1.1 as much as seven times more "immune-evasive" than BA.5.
But even if the new subvariants do surge this winter, most experts think any uptick in infections won't hit as hard as the first two winter surges of the pandemic.
"We are hoping that the amount of immunity that has been induced either by prior infection or by vaccination" will protect most people from getting severely ill or dying, Dr. Anthony Fauci, the White House medical advisor, told NPR.
That said, a new study suggests that getting reinfected with the virus still can pose significant risks, both for short term and long-term complications, including an increased risk of hospitalization, symptoms of long COVID and even death.
"The risk of reinfection is definitely not trivial," says Ziyad Al-Aly, an assistant professor of medicine at Washington University School of Medicine in St. Louis and an author of the new study. "So going into the winter surge now people should do their best to try to prevent getting reinfected."
The study participants, patients from the Veterans Affairs health care system were mostly male and their mean age was over 60, so the findings may not apply to other demographics. Still Al-Aly thinks they're concerning and point to a continued need for taking precautions to avoid COVID.
Because the newly dominant variants appear to be highly immune-evasive, many people may get reinfected.
"The bad news is that it's likely that people who've been vaccinated and/or infected will still get infected" with these new subvariants, says Dr. Daniel Barouch, a virologist at Beth Deaconess Hospital in Boston who's been studying the new strains.
The new strains are becoming dominant just as winter is approaching and people will be traveling and gathering for the holidays, factors that had already raised fears about another winter surge.
"The U.S. is going to see a winter surge in COVID infections," predicts William Hanage, an epidemiologist at the Harvard T.H. Chan School of Public Health. "And I think that if nothing else changes BQ.1 and BQ.1.1 are likely to be very significant players."
The key question is the scale of any winter surge that does emerge.
"The question is whether this increase is going to be nationwide and whether the size of the increase and the surge will be something like what we experienced with delta and omicron, or much smaller," says Samuel Scarpino, vice president of Pathogen Surveillance for the Rockefeller Foundation.
"I think it's quite concerning," he adds.
Infections, and even hospitalizations, have already started inching up in some parts of the country.
One promising sign is that recent surges in other countries suggest that if the subvariants are involved in a new U.S. wave, any uptick could be short-lived. For example, while France experienced a surge involving the new subvariants, the increase in cases quickly receded.
Nevertheless, experts are urging more people to get one of the updated boosters, which for the first time target omicron.
"Hopefully, more people will go and get their updated vaccine — the bivalent vaccine," Fauci says. "That will mitigate a real surge and at worst we'll get a blip versus a major surge."
While some preliminary studies have questioned whether the new boosters are any better than the original vaccine at protecting against omicron, others have suggested they may be. Vaccine makers Pfizer and BioNTech recently released a statement saying their new booster stimulates much higher levels of antibodies that can neutralize the BA.5 omicron subvariant than the original vaccine.
Another concern is that these new subvariants are likely to render the last monoclonal antibody drugs useless, including one that people with compromised immune systems use to protect themselves.
"The winter is going to be especially worrying for people who are immunocompromised," Harvard's Hanage says.
veryGood! (1)
Related
- 'Cowboy Carter' collaborators to be first country artists to perform at Rolling Loud
- Big Little Lies Fans: Get Your First Look at Liane Moriarty’s Next Show Apples Never Fall
- Texas inmate facing execution for 2000 fatal shooting says new evidence points to his innocence
- Adele Pauses Las Vegas Residency Over Health Concerns
- FSU football fires offensive, defensive coordinators, wide receivers coach
- Samsung unveils new wearable device, the Galaxy Ring: 'See how productive you can be'
- Jury finds 2 men guilty on all counts in Jam Master Jay murder trial
- Home for Spring Break? Here's How To Make Your Staycation Feel Like a Dream Getaway
- Groups seek a new hearing on a Mississippi mail-in ballot lawsuit
- In today's global migrant crisis, echoes of Dorothea Lange's American photos
Ranking
- Disease could kill most of the ‘ohi‘a forests on Hawaii’s Big Island within 20 years
- How often is leap year? Here's the next leap day after 2024 and when we'll (eventually) skip one
- Sen. Tammy Duckworth to bring up vote on bill to protect access to IVF nationwide
- Of course Shohei Ohtani hit a home run in his Dodgers debut. 'He's built differently.'
- Tony Todd, star of 'Candyman,' 'Final Destination,' dies at 69
- 'The Voice': Watch the clash of country coaches Reba and Dan + Shay emerge as they bust out blocks
- US economy grew solid 3.2% in fourth quarter, a slight downgrade from government’s initial estimate
- American women's cycling team suspended after dressing mechanic as a rider to avoid race disqualification
Recommendation
-
Ranked voting will decide a pivotal congressional race. How does that work?
-
Essential winter tips on how to drive in the snow from Bridgestone's winter driving school
-
Kids play hockey more skillfully and respectfully than ever, yet rough stuff still exists on the ice
-
Bradley Cooper Shares He’s Not Sure He Would Be Alive If Not for Daughter Lea
-
Diddy's ex-bodyguard sues rape accuser for defamation over claims of 2001 assault
-
A new Wendy Williams documentary raises more questions than it answers
-
Shohei Ohtani won’t pitch this season after major elbow surgery, but he can still hit. Here’s why
-
Ned Blackhawk’s ‘The Rediscovery of America’ is a nominee for $10,000 history prize